Astria Therapeutics, Inc. Operating Lease Liability
Astria Therapeutics, Inc. had Operating Lease Liability of $4.46 million as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2025-11-12
- 2025-09-30: Operating Lease, Liability $4.46M.
- 2025-06-30: Operating Lease, Liability $4.77M.
- 2025-03-31: Operating Lease, Liability $5.06M.
- 2024-12-31: Operating Lease, Liability $5.35M.
| Period end | Operating Lease, Liability |
|---|---|
| 2025-09-30 | $4.46M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $4.77M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $5.06M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $5.35M 10-K · filed 2025-03-11 |
| 2024-09-30 | $5.64M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $5.79M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $168.00K 10-Q · filed 2024-05-09 |
| 2024-01-31 | $5.80M 10-Q · filed 2025-11-12 |
| 2024-01-03 | $5.80M 10-Q · filed 2025-05-13 |
| 2023-12-31 | $329.00K 10-K · filed 2024-03-04 |
| 2023-09-30 | $488.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $643.00K 10-Q · filed 2023-08-07 |
| 2023-03-31 | $794.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $939.00K 10-K · filed 2023-03-22 |
| 2022-09-30 | $1.08M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $1.22M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $184.00K 10-Q · filed 2022-05-12 |
| 2022-01-28 | $1.30M 10-K · filed 2023-03-22 |
| 2021-12-31 | $400.00K 10-K · filed 2022-03-10 |
| 2020-12-31 | $1.05M 10-K/A · filed 2021-04-19 |
| 2019-11-30 | $1.70M 10-K · filed 2022-03-10 |